• Dexcom, founded in 1999, is a global leader in continuous glucose monitoring (CGM) technology for individuals living with diabetes.

BATU KAWAN (Nov 12): US-based medical devices company Dexcom Inc has officially opened its new manufacturing facility, also its first offshore manufacturing site outside the US, in Batu Kawan, Penang.

Penang Chief Minister Chow Kon Yeow said the RM2.83 billion strategic investment will bring more than 3,000 jobs to the state, contributing to a workforce set to positively impact the lives of over three million people worldwide.

Dexcom, founded in 1999, is a global leader in continuous glucose monitoring (CGM) technology for individuals living with diabetes.

“The establishment of this new facility highlights Dexcom’s continued commitment to taking control of health through innovative CGM systems.

“It also reaffirms Penang’s reputation as a global hub for advanced technological industries, reinforcing its position as a preferred destination for high-quality manufacturing and innovation,” the chief minister said in his speech at the opening ceremony here on Tuesday.

Penang Development Corporation chief executive officer Datuk Aziz Bakar, InvestPenang CEO Datuk Loo Lee Lian, and Dexcom chief operating officer Jake Leach were also present at the event.

Chow said Penang is on the right path towards becoming the medical technology (medtech) hub of Southeast Asia by leveraging the state’s over 50 years of industry excellence.

“Housing the largest number of medtech companies nationally and regionally, Penang remains a highly attractive location for its infrastructure availability and ecosystem that meet the needs of the medtech industry.

“For the past five years (2019-2023), Penang garnered a total of RM5.8 billion worth of investments in the scientific and measuring equipment sector, representing 45% of the nation’s total investments in this sector, involving 33 projects and generating an estimated 4,630 employment opportunities,” he said.

Dubbed the Silicon Valley of the East, Penang has reportedly the highest concentration of medtech companies in Malaysia and Southeast Asia to date.

Chow added that Penang maintained its lead as the nation’s top exporter in September, with a 37.5% share or RM46.5 billion of total trade.

Looking to buy a home? Sign up for EdgeProp START and get exclusive rewards and vouchers for ANY home purchase in Malaysia (primary or subsale)!

SHARE
RELATED POSTS
  1. Cabinet approves RM442m upgrade for Kota Kinabalu International Airport
  2. Seremban Engineering hit with RM25m counterclaim related to Bandar Enstek project
  3. Sarawak builder Hartanah Kenyalang files for ACE Market IPO